National Cancer Institute Finally Concedes: ‘Cannabis Kills Cancer’
Now, when you visit the NIH National Cancer Institute’s PDQ updated website summary for “Cannabis and Cannabinoids” you will see a very conflicting message — Cannabis kills cancer, but it is still illegal on a national level.
Yes, something that kills cancer cells is still considered illegal in the United States. If that doesn’t make you furious, I don’t think much of anything else will.
If you’re unfamiliar with the term cannabinoids, they are described as such:
“Currently, the two main cannabinoids from the marijuana plant that are of medical interest are THC and CBD.
THC increases appetite and reduces nausea. The FDA-approved THC-based medications are used for these purposes. THC may also decrease pain, inflammation (swelling and redness), and muscle control problems.
CBD is a cannabinoid that does not affect the mind or behavior. It may be useful in reducing pain and inflammation, controlling epileptic seizures, and possibly even treating mental illness and addictions.
NIH-funded and other researchers are continuing to explore the possible uses of THC, CBD, and other cannabinoids for medical treatment.”
One of those “medical treatments” they are studying? The effect of the drug on cancer.
How does a cannabis treatment have an anti-tumor effect? The site states:
Preclinical studies of cannabinoids have investigated the following activities:
Studies in mice and rats have shown that cannabinoids may inhibit tumor growth by causing cell death, blocking cell growth, and blocking the development of blood vessels needed by tumors to grow. Laboratory and animal studies have shown that cannabinoids may be able to kill cancer cells while protecting normal cells.
A study in mice showed that cannabinoids may protect against inflammation of the colon and may have potential in reducing the risk of colon cancer, and possibly in its treatment.
A laboratory study of delta-9-THC in hepatocellular carcinoma (liver cancer) cells showed that it damaged or killed the cancer cells. The same study of delta-9-THC in mouse models of liver cancer showed that it had antitumor effects. Delta-9-THC has been shown to cause these effects by acting on molecules that may also be found in non-small cell lung cancer cells and breast cancer cells.
A laboratory study of cannabidiol (CBD) in estrogen receptor positive and estrogen receptor negative breast cancer cells showed that it caused cancer cell death while having little effect on normal breast cells. Studies in mouse models of metastatic breast cancer showed that cannabinoids may lessen the growth, number, and spread of tumors.
A laboratory study of cannabidiol (CBD) in human glioma cells showed that when given along with chemotherapy, CBD may make chemotherapy more effective and increase cancer cell death without harming normal cells. Studies in mouse models of cancer showed that CBD together with delta-9-THC may make chemotherapy such as temozolomide more effective.
Yet, the site also says:
“There is not enough evidence to recommend that patients inhale or ingest Cannabis as a treatment for cancer-related symptoms or side effects of cancer therapy.”
“No clinical trials of Cannabis as a treatment for cancer in humans have been found in the CAM on PubMed database maintained by the National Institutes of Health.”
Then maybe get on that!
According to the NIH’s “Drug Facts” asking “is marijuana medicine,” it says:
“Recent animal studies have shown that marijuana can kill certain cancer cells and reduce the size of others. Evidence from one animal study suggests that extracts from whole-plant marijuana can shrink one of the most serious types of brain tumors. Research in mice showed that these extracts, when used with radiation, increased the cancer-killing effects of the radiation.”
On the FDA’s website it reads:
“The FDA has not approved marijuana as a safe and effective drug for any indication. The agency has, however, approved one drug containing a synthetic version of a substance that is present in the marijuana plant and one other drug containing a synthetic substance that acts similarly to compounds from marijuana but is not present in marijuana. Although the FDA has not approved any drug product containing or derived from botanical marijuana, the FDA is aware that there is considerable interest in its use to attempt to treat a number of medical conditions, including, for example, glaucoma, AIDS wasting syndrome, neuropathic pain, cancer, multiple sclerosis, chemotherapy-induced nausea, and certain seizure disorders.
Before conducting testing in humans of a drug that has not been approved by the FDA, an investigator submits an investigational new drug (IND) application, which is reviewed by the FDA.”
We have a potential cure for some cancers and other illnesses sitting at our finger tips, and we seem to be just held back by bureaucratic nonsense. After all, big pharma would HATE to have something that could be grown at home be a cure for cancer. That would be devastating to their profit margins.
You can read the full NIH National Cancer Institute’s summary on the study of Cannabis and Cannabinoids HERE.
Reprinted with permission from Addicting Info